MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident

Stock Information for The Valens Company Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About The Valens Company Inc.

MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
Apollo Capital Wins Proxy Contest at MediPharm Labs
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.